• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer. Curr Gene Ther. 2001 May; 1(1):123-36.

View in: PubMed

subject areas
  • Adenoviridae
  • Apoptosis Regulatory Proteins
  • bcl-2-Associated X Protein
  • Fas Ligand Protein
  • Genetic Therapy
  • Genetic Vectors
  • Humans
  • Male
  • Membrane Glycoproteins
  • Prostatic Neoplasms
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • TNF-Related Apoptosis-Inducing Ligand
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha

authors with profiles
  • James S. Norris
  • Christina Voelkel Johnson